West Pharmaceutical Services Inc. (WST)
NYSE
Closed
Oct 8, 2026
Day's Range
359.4952 wk Range
223.83Overview - WST - West Pharmaceutical Services Inc.
Key Statistics
Valuation
Enterprise Value
25.56B
P/E (Trailing)
‪46.67‬
P/E (Forward)
‪36.56‬
PEG Ratio
‪2.42‬
Price / Sales (TTM)
‪7.72‬
Price / Book
‪8.59‬
EV / EBITDA
‪28.03‬
Profitability
Gross Margin
‪37.73%‬
Profit Margin
‪16.98%‬
Operating Margin
‪22.46%‬
Return on Assets
‪11.37%‬
Return on Equity
‪19.08%‬
Ownership
Shares Outstanding
70.40M
Float
69.84M
Short % of Shares Outstanding
‪3.95%‬
Held by Insiders
‪0.65%‬
Held by Institutions
‪101.93%‬
Price stats
Beta
‪1.13‬
50-Day Avg
‪351.64‬
200-Day Avg
‪301.85‬
Dividends
Payout Ratio
‪11.14%‬
Frequency
Quarterly
Analyst Consensus
17 analysts
Average price target
‪$ 404.73‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - WST - West Pharmaceutical Services Inc.
Peers - WST - West Pharmaceutical Services Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - WST - West Pharmaceutical Services Inc.
About
West Pharmaceutical Services Inc. is a healthcare products manufacturer focused on the design, development, and production of containment and delivery systems for injectable drugs and other healthcare products. The company supplies critical components such as stoppers, seals, syringe and cartridge parts,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
